EUVIMEDEUVIMED entdecken
Open Access

Diagnosis and treatment of lung cancer in Denmark during the COVID-19 pandemic

Tina Bech Olesen, Torben Riis Rasmussen, Erik Jakobsen, Henriette Engberg, Ole Hilberg, Henrik Møller, Jens Winther Jensen, Henry Jensen

Cancer Epidemiology · 2023

DOI: 10.1016/j.canep.2023.102373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Epidemiology, 2023. Verfasst von Tina Bech Olesen und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Danish Clinical Quality Program, National Clinical Registries (RKKP), Denmark. Hauptthemen laut MEDLINE: Lung Neoplasms, COVID-19, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We examined the number of lung cancers diagnosed, the quality of care and the socio-economic and clinical characteristics among patients with lung cancer during the COVID-19 pandemic compared to previous years. METHODS: We included all patients ≥ 18 years old diagnosed with lung cancer from 01 January 2018 to 31 August 2021 as registered in the Danish Lung Cancer Registry. Using a generalised linear model, we estimated prevalence ratios (PR) and 95% confidence intervals (CI) of the associations between the pandemic and socioeconomic and clinical factors, and indicators of quality. RESULTS: We included 18,113 patients with lung cancer (82.0% non-small cell lung cancer (NSCLC)), which was similar to the preceding years, although a decline in NSCLC cases occurred during the first lockdown period in 2020. No difference in distribution of income or educational level was observed. No difference was observed in the quality of treatment - as measured by curative intent, proportion of patients resected or who died within 90 days of diagnosis. CONCLUSION: Using nationwide population-based data, our study reassuringly shows no adverse effects of the COVID-19 pandemic on the diagnosis, socio-economic characteristics nor quality of treatment of lung cancer, as compared to the preceding years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCOVID-19Carcinoma, Non-Small-Cell LungHumansAdolescentPandemicsCommunicable Disease ControlDenmarkCOVID-19 Testing

Stichwörter der Autor:innen

COVID-19 pandemicLung cancerQuality of care, Socio-economic factors, Epidemiology

Autor:innen und Institutionen

  • The Danish Clinical Quality Program, National Clinical Registries (RKKP), Denmark.
  • Department of Clinical Medicine, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Thoracic, Cardiac and Vascular Surgery, Odense University Hospital (OUH), Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Internal Medicine, Lillebaelt Hospital, Vejle, Denmark; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • The Danish Clinical Quality Program, National Clinical Registries (RKKP), Denmark. Electronic address: HERJEN@rkkp.dk.

Zitieren

APA

Olesen, T. B., Rasmussen, T. R., Jakobsen, E., Engberg, H., Hilberg, O., Møller, H., Jensen, J. W., & Jensen, H. (2023). Diagnosis and treatment of lung cancer in Denmark during the COVID-19 pandemic. Cancer Epidemiology. https://doi.org/10.1016/j.canep.2023.102373

Vancouver

Olesen TB, Rasmussen TR, Jakobsen E, Engberg H, Hilberg O, Møller H, et al. Diagnosis and treatment of lung cancer in Denmark during the COVID-19 pandemic. Cancer Epidemiology. 2023. doi:10.1016/j.canep.2023.102373

BibTeX
@article{Olesen2023,
  author = {Olesen, Tina Bech and Rasmussen, Torben Riis and Jakobsen, Erik and Engberg, Henriette and Hilberg, Ole and Møller, Henrik and Jensen, Jens Winther and Jensen, Henry},
  title = {Diagnosis and treatment of lung cancer in Denmark during the COVID-19 pandemic},
  journal = {Cancer Epidemiology},
  year = {2023},
  doi = {10.1016/j.canep.2023.102373}
}
Kostenlos starten →